维普中文期刊产品整合服务
24篇 您的检索式:作者名="Jeruss JS"
    题名 作者 年代 出处 被引量
1Preservation of fertility in patients with cancer显示文摘Jeruss JS Woodruff TK 0,,09:1
2Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy 显示文摘Jeruss JS Mittendorf EA Tucker SL 2008Clin Oncol2008,26,:1
3Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy显示文摘Jeruss JS Mittendorf EA Tucker SL 2008ClinOneol2008,26,2:1
4Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast显示文摘Jeruss JS Vicini FA Beitsch PD 2006Ann SurgOncol2006,13,7:1
5Staging of breast cancer in the neoadjuvant setting显示文摘Jeruss JS Mittendorf EA Tucker SL 2008Cancer Res2008,68,16:1
6Preservation of fertility in patients with cancer显示文摘Jeruss JS Woodruff TK 2009N Engl J Med2009,360,9:1
7Staging of breast cancer in the neoadjuvant setting显示文摘Jeruss JS Mittendorf EA Tucker SL 2008Cancer Res2008,68,:1
8Staging of breast cancer in the neoadjuvant setting 显示文摘Jeruss JS Mittendorf EA Tucker SL 2008Cancer Res2008,68,16:1
9Staging of breast cancer in the neoadjuvant setting显示文摘Jeruss JS Mittendorf CA Tucker SL 2008Cancer Res2008,68,16:1
10Initial outcomes for pa- tients treated on the American Society of Breast Surgeons Mammos- ite clinical trial for ductal carcinoma-in-situ of the breast 显示文摘Jeruss JS Vicini FA Beitsch PD ct al 2006Ann Surg Oncol2006,13,7:1
11Maintaining fertility in young women with breast cancer 显示文摘Hulvat MC Jeruss JS 2009Curr Treat Options Oncol2009,10,56:1
12Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy 显示文摘Jeruss JS Newman LA Ayers GD 2008Cancer2008,112,12:1
13Preservation of fertility in patients with cancer显示文摘Jeruss JS Woodruff TK 2009New Engl J Med2009,360,25:1
14Reeva- luating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology显示文摘Abbott DE Margaryan NV Jeruss JS 2010Cancer Biol Ther2010,9,1:1
15Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy显示文摘Jeruss JS Mittendorf EA Tucker SL 2008J Clin Oncol2008,26,2:1
16Axillary recurrence af- ter sentinel node biopsy显示文摘Jeruss JS Winchester D J Sener SF 2005Ann Surg Oncol2005,12,1:1
17Preservation of fertility in patients with cancer显示文摘Jeruss JS Woodruff TK 2009New England Journal of Medicine2009,360,9:1
18Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology显示文摘Abbott DE Margaryan NV Jeruss JS 2010Cancer Biol Ther2010,9,1:1
19Fertility preservation options for young women with breast cancer显示文摘Hulvat MC Jeruss JS 2011Curt Opin Obstet Gynecol2011,23,3:1
20Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells 显示文摘Burdette JE Jeruss JS Kurley SJ 2005Cancer Res2005,65,17:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费